Systemic mobilization of antigen presenting cells, with a chimeric Flt-3 and G-CSF receptor agonist, during immunization of Macaca mulatta with HIV-1 antigens is insufficient to modulate immune responses or vaccine efficacy

Vaccine

Volumn 23, Issue 33, 2005, Pages 4195-4202

  Koopman, Gerrit ^a   Mortier, D ^a   Niphuis, H ^a   Farese, Ann M ^b   Kahn, Larry E ^c   Mann, Dean ^b   Wagner, Ralf ^d   MacVittie, Thomas J ^b   Woulfe, Susan L ^c   Heeney, Jonathan L ^a  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b UNIVERSITY OF MARYLAND   (United States)

^c Pharmacia Research   (United States)

^d UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Dendritic cell; Flt 3 ligand; HIV vaccine

Indexed keywords

DNA VACCINE; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; VASCULOTROPIN RECEPTOR 3; VIRUS VECTOR;

ANIMAL MODEL; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL COUNT; CELL MATURATION; CELL MOTILITY; CONTROLLED STUDY; DENDRITIC CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IN VIVO STUDY; MACACA; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS LOAD;

EID: 22144472176     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.04.008     Document Type: Article

References (53)

1. C. Caux, C. Dezutter-Dambuyant, D. Schmitt, and J. Banchereau GM-CSF and TNFα cooperate in the generation of dendritic langerhans cells Nature 360 1992 258 261
2. U. O'Doherty, R.M. Steinman, M. Peng, P.U. Cameron, S. Gezelter, and I. Kopeloff Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium J Exp Med 178 3 1993 1067 1076
3. S. Patterson, J. Gross, N. English, A. Stockpoole, P. Bedford, and S.C. Knight CD4 expression on dendritic cells and their infection by human immunodeficiency virus J. Gen. Virol. 76 1995 1155 1163
4. U. O'Doherty, M. Peng, S. Gezelter, W.J. Swiggard, M. Betjes, and N. Bhardwaj Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature Immunology 82 3 1994 487 493
5. M.C. Rissoan, V. Soumelis, N. Kadowaki, G. Grouard, F. Briere, and R. de Waal Malefyt Reciprocal control of T helper cell and dendritic cell differentiation Science 283 5405 1999 1183 1186
6. M. Cella, D. Jarrossay, F. Facchetti, O. Alebardi, H. Nakajima, and A. Lanzavecchia Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon [see comments] Nat Med 5 8 1999 919 923
7. A. D'Amico, and L. Wu The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3 J Exp Med 198 2 2003 293 303
8. Y. Ebihara, M.J. Xu, A. Manabe, A. Kikuchi, R. Tanaka, and S. Kato Exclusive expression of G-CSF receptor on myeloid progenitors in bone marrow CD34+ cells Br J Haematol 109 1 2000 153 161
9. J. Iwasaki-Arai, H. Iwasaki, and T. Miyamoto Watanabe S,Akashi K. Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion J Exp Med 197 10 2003 1311 1322
10. C.L. Semerad, J. Poursine-Laurent, F. Liu, and D.C. Link A role for G-CSF receptor signaling in the regulation of hematopoietic cell function but not lineage commitment or differentiation Immunity 11 2 1999 153 161
11. B. Pulendran, J. Banchereau, S. Burkeholder, E. Kraus, E. Guinet, and C. Chalouni Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo J Immunol 165 1 2000 566 572
12. G.Y. Ishioka, J. Fikes, M. Qin, C. Gianfrani, R.W. Chesnut, and L.E. Kahn Dendritic cells generated in vivo by a chimeric hematopoietic growth factor, progenipoietin-4, demonstrate potent immunological function Vaccine 19 27 2001 3710 3719
13. E. Maraskovsky, E. Daro, E. Roux, M. Teepe, C.R. Maliszewski, and J. Hoek In vivo generation of human dendritic cell subsets by Flt3 ligand Blood 96 3 2000 878 884
14. P.T. Coates, S.M. Barratt-Boyes, L. Zhang, V.S. Donnenberg, P.J. O'Connell, and A.J. Logar Dendritic cell subsets in blood and lymphoid tissue of rhesus monkeys and their mobilization with Flt3 ligand Blood 102 7 2003 2513 2521
15. G. Koopman, H. Niphuis, A.G. Haaksma, A.M. Farese, D.B. Casey, and L.E. Kahn Increase in plasmacytoid and myeloid dendritic cells by progenipoietin-1, a chimeric Flt-3 and G-CSF receptor agonist, in SIV-Infected rhesus macaques Hum Immunol 65 4 2004 303 316
16. B. Pulendran, J.L. Smith, M. Jenkins, M. Schoenborn, E. Maraskovsky, and C.R. Maliszewski Prevention of peripheral tolerance by a dendritic cell growth factor: flt3 ligand as an adjuvant [In Process Citation] J Exp Med 188 11 1998 2075 2082
17. B. Pulendran, J.L. Smith, G. Caspary, K. Brasel, D. Pettit, and E. Maraskovsky Distinct dendritic cell subsets differentially regulate the class of immune response in vivo Proc Natl Acad Sci U S A 96 3 1996 1036 1041
18. K.D. Somers, R.R. Brown, D.A. Holterman, N. Yousefieh, W.F. Glass, and G.L. Wright Jr. Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: efficacy of flt3 ligand immunotherapy Int J Cancer 107 5 2003 773 780
19. D.H. Lynch Induction of dendritic cells (DC) by Flt3 Ligand (FL) promotes the generation of tumor-specific immune responses in vivo Crit Rev Immunol 18 1-2 1998 99 107
20. T.G. Evans, M. Hasan, L. Galibert, and D. Caron The use of Flt3 ligand as an adjuvant for hepatitis B vaccination of healthy adults Vaccine 21 3-4 2002 322 329
21. P.J. Mosca, A.C. Hobeika, K. Colling, T.M. Clay, E.K. Thomas, and D. Caron Multiple signals are required for maturation of human dendritic cells mobilized in vivo with Flt3 ligand J Leukoc Biol 72 3 2002 546 553
22. A.M. Farese, D.B. Casey, R.M. Vigneulle, W.G. Smith, S.L. Woulfe, and T.J. MacVittie Progenipoietin, in an abbreviated (QOD) schedule, stimulates superior multilineage hematopoietic recovery as compared to Flt-3 and/or G-CSF Blood 94 1999 48a
23. W.H. Fleming, J.M. Mulcahy, J.P. McKearn, and P.R. Streeter Progenipoietin-1: a multifunctional agonist of the granulocyte colony- stimulating factor receptor and fetal liver tyrosine kinase-3 is a potent mobilizer of hematopoietic stem cells Exp Hematol 29 8 2001 943 951
24. L.E. Kahn, A.M. Farese, and T.J. MacVittie Progenipoietin G promotes in vivo expansion of hematopoietic progenitor cells in mice and in nonhuman primates Blood 90 1997
25. P.R. Streeter, N.I. Minster, L.E. Kahn, W.F. Hood, L.E. Vickery, and T.L. Thurman Progenipoietins: biological characterization of a family of dual agonists of fetal liver tyrosine kinase-3 and the granulocyte colony- stimulating factor receptor Exp Hematol 29 1 2001 41 50
26. N.L. Letvin, D.H. Barouch, and D.C. Montefiori Prospects for vaccine protection against HIV-1 infection and AIDS Annu Rev Immunol 20 2002 73 99
27. D.A. Garber, and M.B. Feinberg AIDS vaccine development: the long and winding road AIDS Rev 5 3 2003 131 139
28. A.J. McMichael, and T. Hanke HIV vaccines 1983-2003 Nat Med 9 7 2003 874 880
29. J. Heeney AIDS: a disease of impaired Th-cell renewal? Immunol Today 16 1995 515 520
30. R.C. Desrosiers Prospects for an AIDS vaccine Nat Med 10 3 2004 221 223
31. R.R. Amara, F. Villinger, J.D. Altman, S.L. Lydy, S.P. O'Neil, and S.I. Staprans Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine Science 292 5514 2001 69 74
32. D.H. Barouch, S. Santra, M.J. Kuroda, J.E. Schmitz, R. Plishka, and A. Buckler-White Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination J Virol 75 11 2001 5151 5158
33. P. Mooij, I.G. Nieuwenhuis, C.J. Knoop, R.W. Doms, W.M. Bogers, and P.J. Ten Haaft Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infection J Virol 78 7 2004 3333 3342
34. H.L. Robinson, D.C. Montefiori, R.P. Johnson, K.H. Manson, M.L. Kalish, and J.D. Lifson Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations [see comments] Nat Med 5 5 1999 526 534
35. N.F. Rose, P.A. Marx, A. Luckay, D.F. Nixon, W.J. Moretto, and S.M. Donahoe An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants Cell 106 5 2001 539 549
36. L.H. Gold, H.S. Fox, S.J. Henriksen, M.J. Buchmeier, M.R. Weed, and M.A. Taffe Longitudinal analysis of behavioral, neurophysiological, viral and immunological effects of SIV infection in rhesus monkeys J Med Primatol 27 2-3 1998 104 112
37. E. Ramsburg, N.F. Rose, P.A. Marx, M. Mefford, D.F. Nixon, and W.J. Moretto Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol J Virol 78 8 2004 3930 3940
38. K.A. Reimann, J.T. Li, G. Voss, C. Lekutis, K. Tenner-Racz, and P. Racz An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/huma mmunodeficiency virus in rhesus monkeys J Virol 70 1996 3198 3206
39. G.B. Karlsson, M. Halloran, J. Li, I.W. Park, R. Gomila, and K.A. Reimann Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys J Virol 71 6 1997 4218 4225
40. K.A. Reimann, J.T. Li, R. Veazey, M. Halloran, I.W. Park, and G.B. Karlsson A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS - like disease after in vivo passage in rhesus monkeys J Virol 70 1996 6922 6928
41. P. Ten Haaft, B. Verstrepen, K. Uberla, B. Rosenwirth, and J. Heeney A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques J Virol 72 12 1998 10281 10285
42. E.J. Verschoor, P. Mooij, H. Oostermeijer, M. van der Kolk, P. ten Haaft, and B. Verstrepen Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance J Virol 73 4 1999 3292 3300
43. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 6673 1998 245 252
44. R.R. Amara, J.M. Smith, S.I. Staprans, D.C. Montefiori, F. Villinger, and J.D. Altman Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine J Virol 76 12 2002 6138 6146
45. N.A. Doria-Rose, C. Ohlen, P. Polacino, C.C. Pierce, M.T. Hensel, and L. Kuller Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge J Virol 77 21 2003 11563 11577
46. J.W. Shiver, T.M. Fu, L. Chen, D.R. Casimiro, M.E. Davies, and R.K. Evans Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity Nature 415 6869 2002 331 335
47. T.U. Vogel, H. Horton, D.H. Fuller, D.K. Carter, K. Vielhuber, and D.H. O'Connor Differences between T cell epitopes recognized after immunization and after infection J Immunol 169 8 2002 4511 4521
48. S. Casares, K. Inaba, T.D. Brumeanu, R.M. Steinman, and C.A. Bona Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope J Exp Med 186 9 1997 1481 1486
49. D. Haddad, J. Ramprakash, M. Sedegah, Y. Charoenvit, R. Baumgartner, and S. Kumar Plasmid vaccine expressing granulocyte-macrophage colony-stimulating factor attracts infiltrates including immature dendritic cells into injected muscles J Immunol 165 7 2000 3772 3781
50. S.M. Sumida, P.F. McKay, D.M. Truitt, M.G. Kishko, J.C. Arthur, and M.S. Seaman Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines J Clin Invest 114 9 2004 1334 1342
51. M.V. Dhodapkar, R.M. Steinman, J. Krasovsky, C. Munz, and N. Bhardwaj Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells J Exp Med 193 2 2001 233 238
52. D. Hawiger, K. Inaba, Y. Dorsett, M. Guo, K. Mahnke, and M. Rivera Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo J Exp Med 194 6 2001 769 779
53. L. Bonifaz, D. Bonnyay, K. Mahnke, M. Rivera, M.C. Nussenzweig, and R.M. Steinman Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance J Exp Med 196 12 2002 1627 1638